Thanks for the article.
USD 4.9b, about AUD 7.5b. At current sp level they could get CHM for AUD 7.5m, a 1/1000 of that.
While AUD 7.5b was definitely too much, AUD 7.5m is definitely not enough considering all the other platforms, especially the GBM.
GLTA
Ann: 1st patient treated in ADVENT-AML Phase 1b clinical trial, page-4
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.002(11.1%) |
Mkt cap ! $17.25M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 2.1¢ | 1.9¢ | $56.44K | 2.801M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1655923 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 1520755 | 2 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| CHM (ASX) Chart |